{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:40:02Z","timestamp":1752208802048,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Osteoporosis (OP) is common in the elderly, who typically have multiple comorbidities. Current guidelines for managing drug-induced OP are limited due to the complexity of multi-agent medications and the lack of sufficient clinical data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Information of demographics, health status, prescription medication use, OP diagnoses, and bone fracture history in US adults aged \u226550 years was from NHANES. Administration of individual medication ingredients was extracted and association between medication component use and OP diagnosis was determined. National trends in OP diagnosis, prescription medication use, and medication ingredient administrations were examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>OP diagnosis prevalence rose from 9.00% to 13.23% during 1999\u2013March 2020 (p-trend = 0.00). Increased medication prescription was noted in OP patients (p-trend<jats:sub>No. prescription medications=4\u20137<\/jats:sub> &amp;lt;0.0001, p-trend<jats:sub>No. prescription medications\u22658<\/jats:sub> &amp;lt; 0.0001, and p-trend<jats:sub>Days taking medications\u2265500<\/jats:sub> &amp;lt; 0.0001). Thirty-four medication ingredients were correlated with OP diagnosis, including three OP-specific medications, three avoided in OP patients in current practice, seven contribute to OP but commonly prescribed, four relieved OP when treating diseases causing secondary OP, two bone health-friendly agents, and 15 lack of prior statistical records to support their clinical use in OP. Amongst 10 ingredients associated with OP diagnosis may be underlying their roles in regulating bone remodeling, sympathetic activity, and gastric acidity, whereas the remaining five were not clear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings of this study contribute to updating and improving the existing guidelines. Efforts are recommended to examine how the use of medications contribute to OP and to identify alternative treatments for comorbidities.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1522937","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:10:24Z","timestamp":1752207024000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteoporosis diagnosis and ingredients of prescription medications: a population-based study"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaohong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhendong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bone.2013.08.013","article-title":"Proton pump inhibitor use and fracture risk\u2014effect modification by histamine H1 receptor blockade. Observational case\u2013control study using national prescription data","volume":"57","author":"Abrahamsen","year":"2013","journal-title":"Bone"},{"key":"B2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.56718\/ijp.24-015","article-title":"Assessing the relationship between opioid therapy and osteoporosis","volume":"15","author":"Ali","year":"2024","journal-title":"Int. J. Pain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4103\/2249-4863.192338","article-title":"Impact of antiepileptic drugs on bone health: need for monitoring, treatment, and prevention strategies","volume":"5","author":"Arora","year":"2016","journal-title":"J. Fam. Med. Prim. Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/14740338.2023.2203481","article-title":"Benefit and risk evaluation of quinapril hydrochloride","volume":"22","author":"Barkhordarian","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2353\/ajpath.2009.080871","article-title":"Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts","volume":"174","author":"Biosse-Duplan","year":"2009","journal-title":"Am. J. Pathology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis\u2010related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J. bone mineral Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jaci.2019.01.049","article-title":"Loss of bronchoprotection with ICS plus LABA treatment, \u03b2-receptor dynamics, and the effect of alendronate","volume":"144","author":"Cardet","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/00033197231226275","article-title":"The role of the receptor activator of nuclear factor Kappa-B ligand\/osteoprotegerin ratio in vascular diseases: a therapeutic approach","volume":"76","author":"Celebi Torabfam","year":"2024","journal-title":"Angiology"},{"key":"B9","unstructured":"NHANES 1988-2014 data documentation: Prescription medications\u2014drug information\n          \n          \n          2007"},{"key":"B10","doi-asserted-by":"publisher","first-page":"C270","DOI":"10.1152\/ajpcell.00485.2020","article-title":"Emerging roles of calcium-sensing receptor in the local regulation of intestinal transport of ions and calcium","volume":"320","author":"Chanpaisaeng","year":"2021","journal-title":"Am. J. Physiology-Cell Physiology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40779-024-00540-9","article-title":"Bone-organ axes: bidirectional crosstalk","volume":"11","author":"Deng","year":"2024","journal-title":"Mil. Med. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/RMHP.S223118","article-title":"The association between prolonged proton pump inhibitors use and bone mineral density","volume":"12","author":"Fattahi","year":"2019","journal-title":"Risk Manag. Healthc. Policy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","article-title":"Long-term and sequential treatment for osteoporosis","volume":"19","author":"Foessl","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"116596","DOI":"10.1016\/j.bone.2022.116596","article-title":"Bone mass loss in chronic heart failure is associated with sympathetic nerve activation","volume":"166","author":"Guan","year":"2023","journal-title":"Bone"},{"key":"B16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/pl00004148","article-title":"World-wide projections for hip fracture","volume":"7","author":"Gullberg","year":"1997","journal-title":"Osteoporos. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"0","DOI":"10.32598\/irjns.10.1","article-title":"Comparison of vicious effect of oral pantoprazole and famotidine on new bone formation in patients with lumbar spine fusion surgery: a randomized control trial","volume":"10","author":"Haddadi","year":"2024","journal-title":"Iran. J. Neurosurg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/j.1528-1167.2011.03131.x","article-title":"The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy","volume":"52","author":"Heo","year":"2011","journal-title":"Epilepsia"},{"key":"B19","first-page":"210","article-title":"Drugs for treating hypertension and heart disease","volume-title":"Principles of pharmacology for athletic trainers","author":"Houglum","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/nu14030661","article-title":"Embryonic exposure to tryptophan yields bullying victimization via reprogramming the microbiota-gut-brain axis in a chicken model","volume":"14","author":"Huang","year":"2022","journal-title":"Nutrients"},{"key":"B21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12891-024-07553-4","article-title":"Association between hypertension and osteoporosis: a population-based cross-sectional study","volume":"25","author":"Huang","year":"2024","journal-title":"BMC Musculoskelet. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/bcpt.13825","article-title":"The risk of fragility fractures following initiation of gabapentin and pregabalin\u2014A Danish, nationwide, high\u2010dimensional propensity score\u2010matched cohort study","volume":"132","author":"J\u00f8rgensen","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B23","unstructured":"Amoxicillin\/clavulanate\n          \n          \n            \n              Khan\n              S.\n            \n          \n          \n          2023"},{"key":"B24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.9734\/jpri\/2024\/v36i117603","article-title":"Emerging protein and peptide therapeutics for osteoporosis: advances in anabolic and catabolic treatments","volume":"36","author":"Kuril","year":"2024","journal-title":"J. Pharm. Res. Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"key":"B26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/9781119830306.ch20","volume-title":"Anticholinergics. Veterinary anesthesia and analgesia: the sixth edition of lumb and jones","author":"Lerche","year":"2024"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1136\/annrheumdis-2019-215714","article-title":"Diagnosis of osteoporosis in statin-treated patients is dose-dependent","volume":"78","author":"Leutner","year":"2019","journal-title":"Ann. Rheumatic Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2407493121","DOI":"10.1073\/pnas.2407493121","article-title":"Tamsulosin ameliorates bone loss by inhibiting the release of Cl\u2212 through wedging into an allosteric site of TMEM16A","volume":"122","author":"Li","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"BSR20201778","DOI":"10.1042\/BSR20201778","article-title":"Therapeutic potential of liuwei dihuang pill against KDM7A and Wnt\/\u03b2-catenin signaling pathway in diabetic nephropathy-related osteoporosis","volume":"40","author":"Liu","year":"2020","journal-title":"Biosci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e238707","DOI":"10.1001\/jamanetworkopen.2023.8707","article-title":"Prescription stimulant medical and nonmedical use among US secondary school students, 2005 to 2020","volume":"6","author":"McCabe","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00011-022-01608-9","article-title":"Human mast cells induce osteoclastogenesis through cell surface RANKL","volume":"71","author":"Ng","year":"2022","journal-title":"Inflamm. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40780-021-00213-y","article-title":"A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales","volume":"7","author":"Ogawa","year":"2021","journal-title":"J. Pharm. Health Care Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1183\/13993003.00051-2015","article-title":"Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study","volume":"46","author":"Perrin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"E106","DOI":"10.5888\/pcd17.200130","article-title":"Prevalence of multiple chronic conditions among US adults, 2018","volume":"17","author":"Peter","year":"2020","journal-title":"Prev. chronic Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00198-012-2113-8","article-title":"Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease","volume":"24","author":"Ricciardi","year":"2013","journal-title":"Osteoporos. Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00223-008-9188-4","article-title":"Increase in vertebral fracture risk in postmenopausal women using omeprazole","volume":"84","author":"Roux","year":"2009","journal-title":"Calcif. Tissue Int."},{"key":"B37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-3-031-64102-2_16","volume-title":"Thyroid and parathyroid endocrine emergencies. Head and neck and endocrine surgery: from clinical presentation to treatment success","author":"Sakr","year":"2024"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.2147\/DDDT.S466904","article-title":"Effectiveness of spironolactone in reducing osteoporosis and future fracture risk in middle-aged and elderly hypertensive patients","volume":"18","author":"Song","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.5435\/00124635-200700001-00008","article-title":"Racial and ethnic differences in osteoporosis","volume":"15","author":"Thomas","year":"2007","journal-title":"JAAOS-Journal Am. Acad. Orthop. Surg."},{"key":"B40","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamainternmed.2019.0037","article-title":"Association between insurance status and access to hospital care in emergency department disposition","volume":"179","author":"Venkatesh","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.12659\/msm.895512","article-title":"Body mass index may positively correlate with bone mineral density of lumbar vertebra and femoral neck in postmenopausal females","volume":"22","author":"Wu","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"B42","doi-asserted-by":"publisher","first-page":"001","DOI":"10.17352\/amm.000029","article-title":"The effects of carisoprodol on endochondral ossification: a review of the literature and implications for bone health","volume":"6","author":"Yrkm","year":"2022","journal-title":"Ann. Musculoskelet. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2100808","DOI":"10.1002\/advs.202100808","article-title":"Neuronal induction of bone\u2010fat imbalance through osteocyte neuropeptide Y","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jbmr.4548","article-title":"Potential adverse effect of nonsteroidal anti\u2010inflammatory drugs (NSAIDs) on bisphosphonate efficacy: an exploratory post hoc analysis from a randomized controlled trial of clodronate","volume":"37","author":"Zheng","year":"2020","journal-title":"J. Bone Mineral Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1522937\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:10:27Z","timestamp":1752207027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1522937\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":43,"alternative-id":["10.3389\/fphar.2025.1522937"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1522937","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"article-number":"1522937"}}